Oxaliplatin Adjuvant Chemotherapy After Curative Resection of Primary Colon Cancer

Conditions:   Stage II Colon Cancer;   Stage III Colon Cancer Intervention:   Sponsor:   Boryung Pharmaceutical Co., Ltd Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials